DEUTSCHE BANK AG\
BankPosition in KALV — KalVista Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in KALV
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$782,190
+$215,471 QoQ
Shares Held
38,857
+10.7% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 13.094165787374218.ToString("F0")%
Shared 0.ToString("F0")%
None 86.90583421262578.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. KALV ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $782,190 | 38,857 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $566,719 | 35,091 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $368,505 | 30,255 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $321,898 | 28,474 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $370,733 | 32,126 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $303,572 | 35,841 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $253,809 | 21,918 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $186,807 | 15,858 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $144,644 | 12,196 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $141,414 | 11,544 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $114,394 | 11,879 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $84,483 | 9,387 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $118,865 | 15,123 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $70,304 | 10,400 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $148,553 | 10,238 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $104,628 | 10,633 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $189,437 | 12,852 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $186,251 | 14,078 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $274,104 | 15,708 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $289,700 | 12,091 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $320,482 | 12,475 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $203,420 | 10,712 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $95,632 | 7,596 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $81,638 | 6,747 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $33,169 | 4,336 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||